Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +40.03%
#2 aelf aelf +33.32%
#3 Bitway Bitway +28.63%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.90%
#5 Starpower Starpower +20.64%
#6 Pons Pons +20.39%
#7 Decred Decred +14.50%
#8 PondCoin PondCoin +10.24%
#9 Talus Network Talus Network +9.61%
#10 MarsCoin MarsCoin +8.21%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
YS Biopharma Co., Ltd. YS Biopharma Co., Ltd.

YS Biopharma Co., Ltd.

YS
Clasificación en acciones #30057
YS Biopharma Co., Ltd., a biopharmaceutical firm established in Beijing, China,... YS Biopharma Co., Ltd., a biopharmaceutical firm established in Beijing, China, in 2002, specializes in the discovery, development, production, and commercialization of vaccines and therapeutic biologics. Their primary focus is on addressing infectious diseases and cancer. Central to their efforts is a proprietary PIKA immunomodulating technology platform, which supports the creation of preventive and therapeutic biologics for conditions such as Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. The company extends its operations across multiple countries, including China, the United States, Singapore, the United Arab Emirates, and the Philippines.
Precio por acción
$0.715
Última sincronización: 2024-06-18
Capitalización bursátil
$18.41M
Cambio (1 día)
3.61%
Cambio (1 año)
0.00%
País
CN
Comercio YS Biopharma Co., Ltd. (YS)

Categoría

Healthcare
Ganancias de YS Biopharma Co., Ltd. (YS)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di YS Biopharma Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de YS Biopharma Co., Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE